With 20 years of experience in the healthcare industry, Peter helps pharmaceutical, biotech and medical device companies address a wide range of strategic and commercial issues for both in-line and pipeline assets.
Peter is a leader in ZS’s marketing and product launch practices. He works across multiple therapeutic areas, including diabetes/metabolic, oncology/hematology, immunology, CV, CNS, GI, infectious diseases and dermatology. He has led clients through countless strategy, marketing and sales engagements including market opportunity assessment, go-to-market strategy, segmentation, commercial model design and marketing mix.
Previously, Peter was a partner with Rosetta Marketing Strategies, an integrated marketing consultancy and digital agency. Before that, he was a director of marketing at Centocor, a J&J biotechnology company, and an associate principal in McKinsey’s pharmaceutical and medical products practice. Early on, he practiced law with the national law firm of Drinker, Biddle & Reath. A director and vice chairman of Champlain National Bank, Peter served on the board of Correvio, a Swiss specialty pharmaceutical company competing in the CV market.
Peter holds a B.A. from Princeton University, an M.A. in jurisprudence from Oxford University, and a J.D. from Vanderbilt University School of Law.